Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial

Patient-reported experiences and views on the Cytosponge test: a mixed-methods analysis from the BEST3 trial

Objectives The BEST3 trial demonstrated the efficacy and safety of the Cytosponge-trefoil factor 3, a cell collection device coupled with the biomarker trefoil factor 3, as a tool for detecting Barrett’s oesophagus, a precursor of oesophageal adenocarcinoma (OAC), in primary care. In this nested stu...

Full description

Bibliographic Details
Main Authors: Samuel G Smith, Jo Waller, Fiona M Walter, Peter Sasieni, Rebecca C Fitzgerald, Irene Debiram-Beecham, Greg Rubin, Judith Offman, Fiona Scheibl, Jessica Barnes, Roberta Maroni
Format: Article
Language:English
Published: BMJ Publishing Group 2022-04-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/4/e054258.full

Internet

https://bmjopen.bmj.com/content/12/4/e054258.full

Similar Items